Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML (Q66083609)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML |
clinical trial |
Statements
The Clinical Application of Tumor Reversion: A Phase I Study of Sertraline (Zoloft) in Combination With Timed-sequential Cytosine Arabinoside (Ara-C) in Adults With Relapsed and Refractory Acute Myeloid Leukemia (AML) (English)
0 references
11 August 2016
0 references
July 2020
0 references
36
0 references
18 year
0 references
70 year
0 references